Published On: Mon, May 9th, 2016
Uncategorized | By Sylvia Delisle

CDK Global, Inc. (NASDAQ:CDK) Analyst Review


A number of investment brokers have recently updated their price targets on shares of CDK Global, Inc. (NASDAQ:CDK). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

04/06/2016 – CDK Global, Inc. was upgraded to “neutral” by analysts at JP Morgan. They now have a USD 49 price target on the stock.

04/04/2016 – CDK Global, Inc. had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 65 price target on the stock.

02/04/2016 – CDK Global, Inc. was upgraded to “outperform” by analysts at Barrington Research.

01/19/2016 – CDK Global, Inc. was downgraded to “underweight” by analysts at Morgan Stanley. They now have a USD 46 price target on the stock.

07/07/2015 – Wells Fargo began new coverage on CDK Global, Inc. giving the company a “market perform” rating.

05/01/2015 – CDK Global, Inc. had its “hold” rating reiterated by analysts at Zacks.

04/02/2015 – CDK Global, Inc. had its “hold” rating reiterated by analysts at Evercore ISI. They now have a USD 45 price target on the stock.

The share price of CDK Global, Inc. (NASDAQ:CDK) was up +0.62% during the last day of trading, with a day high of 50.11. 1271650 shares were traded during the last session.

The stock’s 50 day moving average is 47.16 and its 200 day moving average is 46.48. The stock’s market capitalization is 7.77B. CDK Global, Inc. has a 52-week low of 39.67 and a 52-week high of 57.89.

View other investors thoughts on CDK Global, Inc. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.

Receive News & Ratings Via Email


Enter your email address below to get the latest news and analysts' ratings for your stocks with MarketBeat's FREE daily email newsletter:


Navigation